-
Mashup Score: 0
As Chalamet plays the singer in the acclaimed biopic A Complete Unknown, the man himself has taken, at 83, to posting on X
Source: www.theguardian.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 58BCR‐ABL testing in the evaluation of neutrophilia - 1 month(s) ago
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hematologists1Tweet-
“ Patients with an ANC <20.0, who do not have basophilia or circulating myeloid precursors should not receive BCR/ABL testing as part of routine neutrophilia evaluation” https://t.co/7ICruwlzYL
-
-
Mashup Score: 3The Discovery of Dicumarol and Its Sequels | Circulation - 1 month(s) ago
Request permissions for this article. From the Department of Biochemistry, University of Wisconsin, Madison, Wis. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download. Miguel D. Saggese, Valeria Ojeda, Gala Ortiz, Laura Casalins, Fernando Gonzal ez, Carlos Ale, Rafael Mateo, Jeff L. Staudinger, Avina Mahroke, Gauri Patel, Cole Dattel, Sahana Reddy, Priyabrata
Source: www.ahajournals.orgCategories: General Medicine News, Hem/OncsTweet-
@AaronGoodman33 https://t.co/HN3uXmka34
-
-
Mashup Score: 17
In a wide-ranging interview with OPB, Druker discussed the work he hopes to do in the future, and the message he wants to send to Oregon Health & Science University.
Source: www.opb.orgCategories: General Medicine News, Hem/OncsTweet-
OHSU’s Brian Druker on morale, cost-cutting, and the plan to acquire Legacy Health - OPB https://t.co/fMwzAMPhF5
-
-
Mashup Score: 17
In a wide-ranging interview with OPB, Druker discussed the work he hopes to do in the future, and the message he wants to send to Oregon Health & Science University.
Source: www.opb.orgCategories: General Medicine News, Hem/OncsTweet-
OHSU’s Brian Druker on morale, cost-cutting, and the plan to acquire Legacy Health - OPB https://t.co/fMwzAMPhF5
-
-
Mashup Score: 31Dr. Brian Druker Resigns as Head of OHSU’s Knight Cancer Institute - 2 month(s) ago
Dr. Brian Druker, the CEO of the Knight Cancer Center at Oregon Health and Science University, is stepping down, according to an email he sent to colleagues this morning. “It is with deep sadness that I am announcing my resignation, effective immediately, as the CEO of the OHSU Knight Cancer Institute,” Druker wrote in the email. “I will be returning to where I started, running my lab and seeing patients, while exploring options for where I can continue to make an impact.” The move comes after months of
Source: www.wweek.comCategories: General Medicine News, Hem/OncsTweet-
Dr. Brian Druker Resigns as Head of OHSU’s Knight Cancer Institute https://t.co/9FSzLAXaAM
-
-
Mashup Score: 31Dr. Brian Druker Resigns as Head of OHSU’s Knight Cancer Institute - 2 month(s) ago
Dr. Brian Druker, the CEO of the Knight Cancer Center at Oregon Health and Science University, is stepping down, according to an email he sent to colleagues this morning. “It is with deep sadness that I am announcing my resignation, effective immediately, as the CEO of the OHSU Knight Cancer Institute,” Druker wrote in the email. “I will be returning to where I started, running my lab and seeing patients, while exploring options for where I can continue to make an impact.” The move comes after months of
Source: www.wweek.comCategories: General Medicine News, Hem/OncsTweet-
Dr. Brian Druker Resigns as Head of OHSU’s Knight Cancer Institute https://t.co/9FSzLAXaAM
-
-
Mashup Score: 31Dr. Brian Druker Resigns as Head of OHSU’s Knight Cancer Institute - 2 month(s) ago
Dr. Brian Druker, the CEO of the Knight Cancer Center at Oregon Health and Science University, is stepping down, according to an email he sent to colleagues this morning. “It is with deep sadness that I am announcing my resignation, effective immediately, as the CEO of the OHSU Knight Cancer Institute,” Druker wrote in the email. “I will be returning to where I started, running my lab and seeing patients, while exploring options for where I can continue to make an impact.” The move comes after months of
Source: www.wweek.comCategories: General Medicine News, Hem/OncsTweet-
Dr. Brian Druker Resigns as Head of OHSU’s Knight Cancer Institute https://t.co/9FSzLAXaAM
-
-
Mashup Score: 7Hematology products from snake venoms - 2 month(s) ago
Venoms have primarily been used to prepare antivenoms for the treatment of snake bites, but they have constituents that might serve other medical needs. These include metalloproteinases, serine proteases, phospholipases, and C-type lectin-like proteins. Some of the products that have been prepared from venoms are procoagulants employed as topical hemostatics, and either applied directly to bleeding wounds or used as adjuncts to surgical procedures to assist in controlling blood loss. Venoms are also a valuable source of laboratory reagents helpful in diagnosing specific coagulation factor deficiencies, identifying lupus anticoagulants, or managing therapeutic anticoagulation.
Source: www.thrombosisresearch.comCategories: General Medicine News, Hem/OncsTweet-
Hematology products from snake venoms - Thrombosis Research https://t.co/g9EZc4WiXZ
-
-
Mashup Score: 4Five-Star Service - 3 month(s) ago
In this narrative medicine essay, an internist-psychiatrist offers a novel way to address physician burnout by celebrating 4.5-star ratings rather than 5-point ratings as the standard of meeting patient care goals to promote achieving a balanced life.
Source: jamanetwork.comCategories: General Medicine News, Hematologists1Tweet-
@AaronGoodman33 https://t.co/LqbHhpEiFT https://t.co/vKvPRr91TW https://t.co/tFdh92FY8k
-
Embracing X and a turn by Timothée Chalamet: how the acclaimed singer is capturing gen Z https://t.co/VGk3WSmnKo